Page last updated: 2024-11-04

rofecoxib and Retinal Neovascularization

rofecoxib has been researched along with Retinal Neovascularization in 2 studies

Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.

Research Excerpts

ExcerptRelevanceReference
"To explore the anti-angiogenesis mechanism of Rofecoxib and determine whether Rofecoxib can be a therapeutic agent for the prevention of retinal neovascularization using a model of retinopathy of prematurity (ROP)."7.81Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression. ( Chen, L; Liu, NN; Sun, YZ; Zhao, N, 2015)
"To explore the anti-angiogenesis mechanism of Rofecoxib and determine whether Rofecoxib can be a therapeutic agent for the prevention of retinal neovascularization using a model of retinopathy of prematurity (ROP)."3.81Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression. ( Chen, L; Liu, NN; Sun, YZ; Zhao, N, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, NN1
Sun, YZ1
Zhao, N1
Chen, L1
Wilkinson-Berka, JL1
Alousis, NS1
Kelly, DJ1
Gilbert, RE1

Other Studies

2 other studies available for rofecoxib and Retinal Neovascularization

ArticleYear
Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression.
    Clinical & experimental ophthalmology, 2015, Volume: 43, Issue:5

    Topics: Animals; Animals, Newborn; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease

2015
COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity.
    Investigative ophthalmology & visual science, 2003, Volume: 44, Issue:3

    Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, A

2003